Comment on ‘Impact of performance status on non-small cell lung cancer patients with a PD-L1 tumour proportion score ≥50% treated with front-line pembrolizumab’

Authors

  • Mehmet Zahid Kocak Medical Oncology Department, Necmettin Erbakan University, Meram, Konya, Turkey

DOI:

https://doi.org/10.1080/0284186X.2021.1889028

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2021-04-03

How to Cite

Zahid Kocak, M. (2021). Comment on ‘Impact of performance status on non-small cell lung cancer patients with a PD-L1 tumour proportion score ≥50% treated with front-line pembrolizumab’. Acta Oncologica, 60(4), 564–565. https://doi.org/10.1080/0284186X.2021.1889028

Issue

Vol. 60 No. 4 (2021): Acta Oncologica

Section

Articles